Prevalence and factors affecting occurrence of type 2 diabetes mellitus in Saudi patients with chronic liver disease

Saudi Journal of Gastroenterology

Volumn 14, Issue 3, 2008, Pages 118-121

  Singal, Ashwani ^a,b,d   Ayoola, Ayobanji ^a,c  

^a King Fahad Central Hospital   (Saudi Arabia)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c Heal Medical Incs   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Cirrhosis; Diabetes mellitus; Hepatocellular carcinoma; Saudi Arabia

Indexed keywords

EID: 46949109001     PISSN: 13193767     EISSN: 19984049     Source Type: Journal    
DOI: 10.4103/1319-3767.41729     Document Type: Article

References (21)

1. Kruszynska YT, McIntyre N. Carbohydrate metabolism In: McIntyre N. Benhamou J-P, Bircher J, Rizzetto M, Rodes J, editors. Offord Textbook of Clinical Hepatology. Oxford: Oxford University Press 1991: p 129-43.
2. Felig P, Sherin R. Carbohydrate homeostasis, liver and diabetes. In: Popper H, Schaffner F, editors. Progress in Liver Disease. Volume V. New York: Grune and Stratton, 1976: p 149-71.
3. Zein CO, Levy C, Basu A, Zein NN. Chronic hepatitis C and type II diabetes mellitus: A prospective cross sectional study. Am J Gastroentrol 2005;100:48-55.
4. Ratziu V, Heurtier A, Bonyhay L, Poynard T, Giral P. Review article: an unexpected virus-host interaction- the hepatitis C-diabetes link. Aliment Pharmacol Ther 2005;22(Suppl. 2):56-60.
5. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9.
6. Petit JM, Bour JB, Gallard-Jos CG, Minello A, Verges B, Guiguet M, et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001:35:279-83.
7. Fraser GM, Harman I, Meller N, Niv Y, Porath A. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B virus infection. Isr J Med Sci 1996;32:526-30.
8. Hui JM, Sud A, Farrell GC, Bandara P, Kench JG, Fung C, et al. Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression. Gastroentrology 2003;125:1695-704.
9. Mehta SH, Brancati FL, Strathdee SA, Pankow JS, Netski D, Coresh J, et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003;38:50-6.
10. Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999;29:328-33.
11. Lecube A, Hernandez C, Genesca J, Esteban JI, Jardi R, Garcia L, et al. High prevalence of glucose abnormalities in patients with hepatitis C virus infection. Diabetes care 2004;27:1171-5.
12. Ayoola EA, Gadour MO. Hepatocellular carcinoma in Saudi Arabia: Role of hepatitis B and C infection. J Gastroentrol Hepatol 2004;19:665-9.
13. Singal AK, Tadros N. Profile of hepatocellular carcinoma in Gizan, Saudi Arabia. J Gastroenterol Hepatol 2002;17:A1048.
14. Ayoola AE, Tobaigy MS, Gadour MO, Ahmad BS, Hamza MK, Ageel AM. The decline of hepatitis B viral infection in Saudi Arabia. Saudi Med J 2003;24:991-5.
15. Akbar DH, Siddique AM, Ahmed MM. Prevalence of type 2 diabetes in patients with hepatitis C and B virus infection in Jeddah, Saudi Arabia. Med Princ Pract 2002;11:82-5.
16. Child CG, Turcotte JG. Surgery and portal hypertension. In: Child CG, editor. The Liver and Portal Hypertension. Philadelphia: WB Saunders, 1964; p 49-51.
17. Elhadd TA, Al-Amoudi AA, Alzahrani AS. Epidemiology, clinical and complications profile of diabetes in Saudi Arabia: A review. Ann Saudi Med 2007;27:241-50.
18. Akbar DH. Is hypertension common in hospitalized type 2 diabetic patients? Saudi Med J 2001;22:139-41.
19. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735-52.
20. Lee MG, Pedersen PL. Glucose metabolism in cancer: Importance of transcription factor-DNA interactions within a short segment of the proximal region of the type II hexokinase promoter. J Biol Chem 2003;278:41047-58.
21. Okuda K. Hepatocelluar carcinoma. Recent progress. Hepatology 1992;15:948-63.